[go: up one dir, main page]

HK1236034A1 - Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases - Google Patents

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases Download PDF

Info

Publication number
HK1236034A1
HK1236034A1 HK17109798.6A HK17109798A HK1236034A1 HK 1236034 A1 HK1236034 A1 HK 1236034A1 HK 17109798 A HK17109798 A HK 17109798A HK 1236034 A1 HK1236034 A1 HK 1236034A1
Authority
HK
Hong Kong
Prior art keywords
oncologic
metabolic
inflammatory
treatment
autoimmune diseases
Prior art date
Application number
HK17109798.6A
Other languages
Chinese (zh)
Other versions
HK1236034B (en
Inventor
Sanne Schroder Glad
Niels Gron Norager
Ian SARVARY
Alex Haahr Gouliaev
Lene Teuber
Luigi Piero Stasi
Original Assignee
纽韦卢森公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 纽韦卢森公司 filed Critical 纽韦卢森公司
Publication of HK1236034A1 publication Critical patent/HK1236034A1/en
Publication of HK1236034B publication Critical patent/HK1236034B/en

Links

Abstract

Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
HK17109798.6A 2014-08-04 2015-07-31 Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases HK1236034B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1450920-2 2014-08-04
SE1451406-1 2014-11-21

Publications (2)

Publication Number Publication Date
HK1236034A1 true HK1236034A1 (en) 2018-03-16
HK1236034B HK1236034B (en) 2022-05-06

Family

ID=

Similar Documents

Publication Publication Date Title
PH12017500164A1 (en) Optionally fused heterocyclyl - substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
CA2956871C (en) Compounds active towards bromodomains
PL3515420T3 (en) Pharmaceutical compositions for use in the therapy of blepharitis
PL3224254T3 (en) Substituted indazoles, process for their preparation, pharmaceutical formulations containing them, and their use for the preparation of medicaments
WO2016004305A3 (en) Inhibitors of bruton's tyrosine kinase
MY193728A (en) Muscarinic receptor agonists
MX2021001231A (en) Heterocyclic compounds and their uses.
MX2015012416A (en) Heterocyclic compounds and their uses.
EP3291818A4 (en) Compositions and methods for delivering therapeutic agents into the colon
HK1236035A1 (en) Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
HK1236034A1 (en) Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
MA40553A (en) Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
MX378175B (en) NOVEL HETEROCYCLIC COMPOUNDS AND THEIR USE IN BOTH MEDICINE AND COSMETICS.
HK40009824A (en) Pharmaceutical composition for use in the treatment of prostate pathologies
EP3434271A4 (en) Use of pharmaceutical composition for the treatment of skin erythema in poikilodermas
HK1236033A1 (en) Compounds active towards bromodomains
EP3222271A4 (en) Stable pharmaceutical composition comprising pemetrexed or pharmaceutically acceptable salt thereof